FEATURED NEWS

    MORE NEWS...

  • VG Life Sciences’ Advisor Gives Preeclampsia Presentation at American Heart Association Conference

    SANTA BARBARA, Calif., September 12, 2014 — VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces that one of its scientific advisors, Dr. Brett Mitchell, PhD, will give an oral presentation today on his preeclampsia research at the American Heart Association Council for High Blood Pressure Research Conference in San Francisco, California. Using pregnant […]


    READ MORE »
  • VG Life Sciences Inc. Progress Update Phase I Cancer Study

    SANTA BARBARA, Calif., September 4, 2014 — VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its physician-initiated IND phase I study to test safety and tolerability of its patented technology in patients with advanced stage solid tumors. Primary investigator and medical oncologist Dr. Tyler Curiel, MD, MPH reported, “the […]


    READ MORE »
  • VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC

    SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) — VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune and infectious diseases. VG Life Sciences is pleased to announce the filing of Form 10 with the Securities & Exchange Commission on June 19, 2014. Form […]


    READ MORE »